304 is a clinical research site located in Centerville, Ohio, United States 45459.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
304 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.
Sponsors: Corcept Therapeutics.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
304 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
304 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.
304 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.